Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4
- PMID: 20170768
- PMCID: PMC2847053
- DOI: 10.1016/j.vaccine.2010.01.067
Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4
Abstract
Francisella tularensis is a category A select agent. J5dLPS/OMP is a novel vaccine construct consisting of detoxified, O-polysaccharide side chain-deficient, lipopolysaccharide non-covalently complexed with the outer membrane protein of N. meningitidis group B. Immunization elicits high-titer polyclonal antibodies specific for the highly-conserved epitopes expressed within the glycolipid core that constitutes gram-negative bacteria (e.g., F. tularensis). Mice immunized intranasally with J5dLPS/OMP exhibited protective immunity to intratracheal challenge with the live vaccine strain, as well as the highly-virulent SchuS4 strain, of F. tularensis. The efficacy of J5dLPS/OMP vaccine suggests its potential utility in immunizing the general population against several different gram-negative select agents concurrently.
(c) 2010 Elsevier Ltd. All rights reserved.
Figures







Similar articles
-
Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.Infect Immun. 2008 Aug;76(8):3664-71. doi: 10.1128/IAI.00374-08. Epub 2008 May 27. Infect Immun. 2008. PMID: 18505805 Free PMC article.
-
An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.Vaccine. 2008 Sep 26;26(41):5276-88. doi: 10.1016/j.vaccine.2008.07.051. Epub 2008 Aug 8. Vaccine. 2008. PMID: 18692537 Free PMC article.
-
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.Vaccine. 2007 May 10;25(19):3781-91. doi: 10.1016/j.vaccine.2007.02.014. Epub 2007 Feb 26. Vaccine. 2007. PMID: 17346863 Free PMC article.
-
Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.Front Cell Infect Microbiol. 2018 May 15;8:154. doi: 10.3389/fcimb.2018.00154. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29868510 Free PMC article. Review.
-
Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.Microbes Infect. 2003 Feb;5(2):135-42. doi: 10.1016/s1286-4579(02)00084-9. Microbes Infect. 2003. PMID: 12650771 Review.
Cited by
-
Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.PLoS One. 2015 Jun 22;10(6):e0130858. doi: 10.1371/journal.pone.0130858. eCollection 2015. PLoS One. 2015. PMID: 26098553 Free PMC article.
-
Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.Clin Vaccine Immunol. 2010 Nov;17(11):1772-80. doi: 10.1128/CVI.00232-10. Epub 2010 Sep 22. Clin Vaccine Immunol. 2010. PMID: 20861324 Free PMC article.
-
Exosome-Based Mitochondrial Delivery of circRNA mSCAR Alleviates Sepsis by Orchestrating Macrophage Activation.Adv Sci (Weinh). 2023 May;10(14):e2205692. doi: 10.1002/advs.202205692. Epub 2023 Mar 25. Adv Sci (Weinh). 2023. PMID: 36965082 Free PMC article.
-
Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia.PLoS One. 2010 Jun 16;5(6):e11156. doi: 10.1371/journal.pone.0011156. PLoS One. 2010. PMID: 20585390 Free PMC article.
-
Chemical synthesis and immunological evaluation of the inner core oligosaccharide of Francisella tularensis.J Am Chem Soc. 2012 Aug 29;134(34):14255-62. doi: 10.1021/ja306274v. Epub 2012 Aug 16. J Am Chem Soc. 2012. PMID: 22867268 Free PMC article.
References
-
- Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Tularemia as a biological weapon: medical and public health management. JAMA. 2001;285(21):2763–73. - PubMed
-
- Johansson A, Ibrahim A, Goransson I, Eriksson U, Gurycova D, Clarridge JE, III, et al. Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis. J.Clin.Microbiol. 2000;38(11):4180–5. - PMC - PubMed
-
- Saslaw S, Eigelsbach HT, Prior JA, Wilson HE, Carhart S. Tularemia vaccine study, II: respiratory challenge. Arch.Int.Med. 1961;107:134–46. - PubMed
-
- Oyston PC, Sjostedt A, Titball RW. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat.Rev.Microbiol. 2004;2(12):967–78. - PubMed
-
- Eigelsbach HT, DOWNS CM. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J.Immunol. 1961;87:415–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources